AMVUTTRA is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Alnylam Pharmaceuticals, Inc.. The primary component is Vutrisiran.
Product ID | 71336-1003_5cff1285-ac61-47d7-a8e5-98fb52d44b27 |
NDC | 71336-1003 |
Product Type | Human Prescription Drug |
Proprietary Name | AMVUTTRA |
Generic Name | Vutrisiran |
Dosage Form | Injection |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2022-06-13 |
Marketing Category | NDA / |
Application Number | NDA215515 |
Labeler Name | Alnylam Pharmaceuticals, Inc. |
Substance Name | VUTRISIRAN |
Active Ingredient Strength | 25 mg/.5mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-06-13 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AMVUTTRA 97057480 not registered Live/Pending |
Alnylam Pharmaceuticals, Inc. 2021-10-03 |
AMVUTTRA 97057473 not registered Live/Pending |
Alnylam Pharmaceuticals, Inc. 2021-10-03 |
AMVUTTRA 90151672 not registered Live/Pending |
Alnylam Pharmaceuticals, Inc. 2020-09-01 |